Overview

Cannabidiol for Treatment Resistant Depression

Status:
Withdrawn
Trial end date:
2021-07-09
Target enrollment:
Participant gender:
Summary
With this study, the investigators will address the following scientific aims: 1. Demonstrate the antidepressant effects of CBD in human adults with treatment refractory MDD as measured by standard rating scales. 2. Confirm CBD's safety profile in human adult patients with MDD.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham